Artificial Intelligence and non-/Micro-Invasive was Cost-Effective in a Randomized Trial
Objectives: We assessed the cost-effectiveness of AI-supported detection of proximal caries in a randomized controlled clustered cross-over superiority trial. Methods: Twenty-three dentists assessed 20 bitewings; 10 of which were randomly evaluated supported by an AI-based software and the other 10 without AI.We evaluated the proportion of true and false positive and negative detections and the treatment decisions taken for each detected lesion (non-invasive, micro-invasive, invasive). Cost-effectiveness was assessed from a public-private-payer perspective in Germany. A Markov simulation model and Monte Carlo microsimulations of posterior permanent teeth were used to analyze cost-effectiveness over patients’ lifetime. Costs were estimated using the German public and private fee catalogues, and our outcome was the time teeth were retained. Results: For detecting early (E2 or D1) lesions (i.e., those usually recommended for non- or micro-invasive management), dentists were significantly more sensitive when using AI. However, treatment decisions determined the lifetime cost-effectiveness: Managing early lesions restoratively (as occurred in many cases in trial) resulted in AI and no AI showing similar effectiveness (tooth retention for a mean (2.5-97.5%) 49 (48-51)) and costs (AI: 330 (250-409) Euro, no AI: 330 (248-410) Euro). If, however, all detected early lesions had been treated non- or micro-invasively, AI was far less costly (266; (200-352) Euro) than no AI. Conclusions: AI applications should not only support caries detection, but also subsequent evidence-based management of caries lesions.
Division: Meeting:2022 IADR/APR General Session (Virtual) Location: Year: 2022 Final Presentation ID:1634 Abstract Category|Abstract Category(s):e-Oral Health Network
Authors
Schwendicke, Falk
( Charite - Universitaetsmedizin Berlin
, Berlin
, Germany
)
Mertens, Sarah
( Charite - Universitaetsmedizin Berlin
, Berlin
, Germany
)
Krois, Joachim
( Charite - Universitaetsmedizin Berlin
, Berlin
, Germany
)
Financial Interest Disclosure: Falk Schwendicke and Joachim Krois are co-founders of dentalxrai Ltd, a startup developing dental radiograph analysis software using artificial intelligence.
SESSION INFORMATION
Interactive Talk Session
e-Oral Health Network I
Saturday,
06/25/2022
, 02:00PM - 03:30PM